We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+27.04%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$329B
AUM Growth
+$45.5B
Cap. Flow
-$19.5B
Cap. Flow %
-5.91%
Top 10 Hldgs %
19.09%
Holding
5,697
New
507
Increased
1,879
Reduced
2,401
Closed
535

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.38B
2
AGN
Allergan plc
AGN
+$1.33B
3
MSFT icon
Microsoft
MSFT
+$961M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$803M
5
AMZN icon
Amazon
AMZN
+$740M

Sector Composition

Rank Sector Weight
1 Technology 14.8%
2 Healthcare 9.1%
3 Financials 9.05%
4 Consumer Discretionary 8.76%
5 Communication Services 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRNT icon
4976
Ceragon Networks
CRNT
$209M
$58K ﹤0.01%
+26,865
New +$56.5K
DUOT icon
4977
Duos Technologies
DUOT
$288M
$58K ﹤0.01%
+12,523
New +$60.7K
ACRS icon
4978
Aclaris Therapeutics
ACRS
$835M
$57K ﹤0.01%
35,112
+11,026
+46% +$14.8K
AYTU icon
4979
AYTU BioPharma
AYTU
$23.7M
$57K ﹤0.01%
201
-102
-34% -$30.9K
VRDN icon
4980
Viridian Therapeutics
VRDN
$2.3B
$57K ﹤0.01%
3,420
BXG
4981
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$56K ﹤0.01%
10,356
-16,877
-62% -$80.5K
PULM icon
4982
Pulmatrix
PULM
$6.06M
$53K ﹤0.01%
+1,528
New +$48.4K
TPST icon
4983
CALL
Tempest Therapeutics
TPST
$14.2M
$53K ﹤0.01%
154
ZVO
4984
DELISTED
Zovio Inc. Common Stock
ZVO
$51K ﹤0.01%
+16,525
New +$37.5K
KA
4985
DELISTED
Kineta, Inc. Common Stock
KA
$50K ﹤0.01%
+260
New +$53.1K
VSTM icon
4986
Verastem
VSTM
$511M
$49K ﹤0.01%
2,402
-7,073
-75% -$187K
PHUN icon
4987
Phunware
PHUN
$44.6M
$48K ﹤0.01%
780
+325
+71% +$15.5K
TOON icon
4988
Kartoon Studios
TOON
$35.4M
$48K ﹤0.01%
+2,154
New +$38.4K
GRIN
4989
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
$47K ﹤0.01%
17,383
EVFM
4990
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$47K ﹤0.01%
+1,117
New +$75.3K
AVAL icon
4991
Grupo Aval
AVAL
$6.19B
$45K ﹤0.01%
+10,279
New +$45.2K
IEAWW
4992
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$45K ﹤0.01%
343,006
PNNT
4993
Pennant Park Investment Corp
PNNT
$230M
$44K ﹤0.01%
+12,434
New +$40.2K
ALNA
4994
DELISTED
Allena Pharmaceuticals
ALNA
$44K ﹤0.01%
+28,112
New +$47.2K
TIGR
4995
UP Fintech Holding
TIGR
$854M
$43K ﹤0.01%
+10,292
New +$33.7K
VTVT icon
4996
vTv Therapeutics
VTVT
$126M
$43K ﹤0.01%
477
+19
+4% +$1.88K
GSS
4997
DELISTED
Golden Star Resources Ltd.
GSS
$43K ﹤0.01%
14,686
-132,531
-90% -$344K
RNET
4998
DELISTED
RigNet, Inc.
RNET
$43K ﹤0.01%
+19,929
New +$28.2K
OESX icon
4999
Orion Energy Systems
OESX
$42.2M
$42K ﹤0.01%
1,223
-8,832
-88% -$361K
BXRX
5000
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$42K ﹤0.01%
+7
New +$33.6K

Similar funds

Goldman Sachs's Q2 2020 Portfolio in Review

As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.

  • Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
  • Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
  • Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
  • Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
  • Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
  • Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.

Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.